Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

Phase 4Post-market surveillance

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (75.0%)

Phase 41 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

NCT00347139

completedphase_4

Chronic Obstructive Pulmonary Disease Endpoints Study

NCT00358358

completedphase_2

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

NCT00358488

completedphase_2

Investigation Of A New Medication (GW642444) In Asthmatic Patients

NCT00354874

Clinical Trials (4)

Showing 4 of 4 trials

NCT00347139Phase 2

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

Completed

NCT00358358Phase 4

Chronic Obstructive Pulmonary Disease Endpoints Study

Completed

NCT00358488Phase 2

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Completed

NCT00354874Phase 2

Investigation Of A New Medication (GW642444) In Asthmatic Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4